JP2011529882A5 - - Google Patents

Download PDF

Info

Publication number
JP2011529882A5
JP2011529882A5 JP2011521126A JP2011521126A JP2011529882A5 JP 2011529882 A5 JP2011529882 A5 JP 2011529882A5 JP 2011521126 A JP2011521126 A JP 2011521126A JP 2011521126 A JP2011521126 A JP 2011521126A JP 2011529882 A5 JP2011529882 A5 JP 2011529882A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
isolated
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011521126A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011529882A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/004420 external-priority patent/WO2010014248A2/en
Publication of JP2011529882A publication Critical patent/JP2011529882A/ja
Publication of JP2011529882A5 publication Critical patent/JP2011529882A5/ja
Pending legal-status Critical Current

Links

JP2011521126A 2008-07-31 2009-07-31 タンパク質シトビリンの抗ウィルス活性及び使用方法 Pending JP2011529882A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13751108P 2008-07-31 2008-07-31
US61/137,511 2008-07-31
PCT/US2009/004420 WO2010014248A2 (en) 2008-07-31 2009-07-31 Antiviral activity of the protein scytovirin and methods of use

Publications (2)

Publication Number Publication Date
JP2011529882A JP2011529882A (ja) 2011-12-15
JP2011529882A5 true JP2011529882A5 (cg-RX-API-DMAC10.html) 2012-09-13

Family

ID=41610899

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011521126A Pending JP2011529882A (ja) 2008-07-31 2009-07-31 タンパク質シトビリンの抗ウィルス活性及び使用方法

Country Status (4)

Country Link
US (1) US20110183894A1 (cg-RX-API-DMAC10.html)
EP (1) EP2320926A2 (cg-RX-API-DMAC10.html)
JP (1) JP2011529882A (cg-RX-API-DMAC10.html)
WO (1) WO2010014248A2 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006002106B4 (de) * 2006-01-17 2016-03-03 Robert Bosch Gmbh Mikromechanischer Sensor mit perforationsoptimierter Membran sowie ein geeignetes Hestellungsverfahren
WO2019108656A1 (en) 2017-11-28 2019-06-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Microbicidal composition
CN112345507B (zh) * 2020-11-06 2022-07-05 济南大学 一种基于dna三棱柱结构构象变化靶向癌细胞的生物传感器
KR20240169648A (ko) 2022-03-24 2024-12-03 다니스코 유에스 인크. 렉틴의 산업적 규모의 생산 및 회수를 위한 조성물 및 방법
US20260092088A1 (en) 2022-09-20 2026-04-02 International N&H Denmark Aps Variant anti-viral polypeptides
EP4735472A1 (en) 2023-06-30 2026-05-06 Danisco US Inc. Recombinant fungal cells and methods thereof for industrial scale production of lectins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097814A2 (en) * 2002-05-16 2003-11-27 The Government Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins
DE602006014140D1 (de) * 2005-05-25 2010-06-17 Us Government Mit scytovirin der domäne 1 verwandte polypeptide

Similar Documents

Publication Publication Date Title
JP6294828B2 (ja) インフルエンザウイルスワクチンおよびその使用
EP2152736B1 (en) Complement factor h-derived short consensus repeat-antibody constructs
Odemuyiwa et al. An outbreak of African swine fever in Nigeria: virus isolation and molecular characterization of the VP72 gene of a first isolate from West Africa
ES2781085T3 (es) Mutantes de griffithsina
JP2012504602A5 (cg-RX-API-DMAC10.html)
JP2017529326A5 (cg-RX-API-DMAC10.html)
Bharadwaj et al. Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice
JP2011504169A5 (cg-RX-API-DMAC10.html)
SG11202107904PA (en) Compositions and methods for stimulating natural killer cells
WO2004085633A8 (en) A novel human virus causing severe acute respiratory syndrome (sars) and uses thereof
CN105111288A (zh) 鲍曼不动杆菌亚单位疫苗抗原蛋白与应用
KR20030024876A (ko) 리바비린 함유 백신 및 이것의 사용 방법
JP2023522154A5 (cg-RX-API-DMAC10.html)
EP2428221B1 (en) Dengue vaccine, pharmaceutical composition comprising the same, nucleotide molecule and antibody composition
EP3342866B1 (en) Polypeptide carrier for presenting target polypeptide and uses thereof
CN104292337A (zh) 猪融合干扰素
ES2348203T3 (es) Eritrovirus y sus aplicaciones.
US20110183894A1 (en) Antiviral activity of the protein scytovirin and methods of use
CN101797381A (zh) 乙肝病毒抗原与路易斯寡糖的复合物及其制备方法和应用
CN105497884B (zh) 外膜蛋白Omp22作为鲍曼不动杆菌疫苗靶点的应用
CN116769048A (zh) 聚合分子、包括其的单一结构和多聚结构
BR9707142A (pt) Polinucleotìdeo purificado, dna, vetor, célula hospedeira, linhagem celular de hibridoma, anticorpo monoclonal, processos para produzir exodus, para aumentar a resistência à infecção por vìrus de imonudeficiência humana (hiv), para tratamento de infecção por vìrus de imonodeficiência humana (hiv), para proteção de células progenitoras de medula óssea contra os efeitos citotóxicos e para tratamento de doenças mieloproliferativas, e, uso de produto de proteina de exodus.
JP2007516214A (ja) 空間構造が変えられるインターフェロン及びその応用
Rashedi et al. Vitamin D3 administration to patients with confirmed COVID-19
CN104356220B (zh) 一种具有血小板聚集抑制功能的抗hiv白纹伊蚊蛋白及其制备方法